glp 1 and suicidal ideation GLP-1 receptor agonists and risk of suicide or suicide attempts – A nationwide cohort and self-controlled case series study

Association of glucagon-like peptide-1 receptor agonists with suicidal ideation and self-injury in individuals with diabetes and obesity: a propensity-weighted, population-based cohort study | Diabetologia

24.91

★★★★☆4.8 (126)

The FDA requested that manufacturers of GLP-1 receptor agonists remove information regarding risks of suicidal behavior and ideation from drug labels following a detailed review of existing data, the agency announced on

21.66

★★★★★4.9 (98)

FDA Moves To Remove Suicide Warnings From GLP-1 Weight Loss Drugs

20.72

★★★★★5.0 (157)

The U.S. health regulator asked drugmakers to remove label warnings about a potential risk of suicidal thoughts from widely used GLP-1 weight-loss drugs, including Novo Nordisk's Wegovy and Eli Lilly's Zepbound. https://cnn.it/49uSrKw

26.46

★★★★★4.7 (84)

Suicide and suicide attempt in users of GLP-1 receptor agonists: a nationwide case-time-control study

20.30

★★★★★4.9 (203)

GLP-1 treatment lowers suicidal ideation risk by 33% in adolescents with obesity, study finds

28.36

★★★★★5.0 (176)

Suicide and suicide attempt in users of GLP-1 receptor agonists: a nationwide case-time-control study

20.23

★★★★★4.8 (132)